Nano-rods of doxorubicin with poly( l -glutamic acid) as a carrier-free formulation for intratumoral cancer treatment
Source abstract
Abstract
In addition to intravenous injections (i.v.), topical dosing of doxorubicin hydrochloride (DOX) has also been the focus of cancer treatment recently, although it normally requires well-designed drug carriers. In this work, we found that DOX could form fibril-shaped DOX aggregates via self-assembly in phosphate buffer (PB) and then co-assemble with poly(l-glutamic acid) (PGA) at a proper polymer-drug ratio, giving a unique nano-rod-shaped microstructure. The release rate of DOX from the PGA/DOX nano-rods was thus easily controlled at a slower release rate without being encapsulated by any classic carrier. In vitro cell culture demonstrated that the PGA/DOX nano-rods were not favorably taken up by cancer cells, which can be attributed to the negatively charged nature and the non-spherical shape of the aggregates. These features suggest great potential for the PGA/DOX assemblies for a sustained delivery through the intratumoral pathway (i.t.) as a carrier-free formulation. In the mouse model it diminished organ damage at a dose level of 30 mg kg-1via i.t. injections compared to the serious cardiotoxicity and renal toxicity via typical multiple i.v. dosage of free drug solution at 5 mg kg-1. As a result, the PGA/DOX formulation showed efficient anti-tumor activity. The survival rate of tumor bearing mice was significantly increased by over 35% compared to the i.v. injections of DOX solutions. Therefore, PGA/DOX nano-rods may provide a new and safe delivery route of the common anti-tumor drug.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Biopolymer Synthesis and Applications · Advanced biosensing and bioanalysis techniques
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
State Key Laboratory of Polymer Physics and Chemistry
Institute of Chemistry
Chinese Academy of Sciences
Beijing 100190
China
College of Materials Science and Opto-Electronic Technology
University of Chinese Academy of Sciences
Beijing 100049
College of Life Science and Technology
Beijing University of Chemical Technology
Beijing 100029
References (43)
Show source-provided references
1. Wang · Biomaterials · 2014 · 35 · 837410.1016/j.biomaterials.2014.05.094 ↗
2. Deng · Acta Biomater. · 2015 · 11 · 12610.1016/j.actbio.2014.09.047 ↗
3. Gao · Macromol. Biosci. · 2012 · 12 · 25110.1002/mabi.201100208 ↗
4. Zhao · J. Controlled Release · 2013 · 168 · 6110.1016/j.jconrel.2013.02.026 ↗
5. Liu · ACS Appl. Mater. Interfaces · 2014 · 6 · 239310.1021/am404734c ↗
6. Lym · Acta Biomater. · 2016 · 41 · 25310.1016/j.actbio.2016.05.018 ↗
7. Zhao · Int. J. Pharm. · 2011 · 410 · 8310.1016/j.ijpharm.2011.03.034 ↗
8. Fakhari · J. Controlled Release · 2015 · 220 · 46510.1016/j.jconrel.2015.11.014 ↗
9. Mallapragada · Nanomed.: Nanotechnol., Biol. Med. · 2015 · 11 · 71510.1016/j.nano.2014.12.013 ↗
10. Liu · Small · 2013 · 9 · 153310.1002/smll.201201531 ↗
11. Zhao · ACS Appl. Mater. Interfaces · 2015 · 7 · 1929510.1021/acsami.5b05347 ↗
12. Zhou · Biomaterials · 2013 · 34 · 896010.1016/j.biomaterials.2013.07.080 ↗
13. Bae · J. Controlled Release · 2007 · 122 · 32410.1016/j.jconrel.2007.05.038 ↗
14. Alberto Gabizon · Cancer Res. · 1994 · 54 · 987
15. Piao · ACS Nano · 2014 · 8 · 1041410.1021/nn503779d ↗
16. Wu · Mol. Pharmaceutics · 2014 · 11 · 337810.1021/mp500019p ↗
17. Mooney · ACS Nano · 2014 · 8 · 1245010.1021/nn505147w ↗
18. Li · ACS Appl. Mater. Interfaces · 2015 · 7 · 803310.1021/acsami.5b00389 ↗
19. Zhu · Polym. Chem. · 2014 · 5 · 570010.1039/C4PY00686K ↗
20. Abraham · Biochim. Biophys. Acta, Biomembr. · 2002 · 1565 · 4110.1016/S0005-2736(02)00507-2 ↗
21. Lasic · Biochim. Biophys. Acta, Biomembr. · 1995 · 1239 · 14510.1016/0005-2736(95)00159-Z ↗
22. Tanaka · J. Phys.: Condens. Matter · 2000 · 12 · R207
23. Lai · RSC Adv. · 2015 · 5 · 4885610.1039/C5RA06755C ↗
24. Sánchez · J. Controlled Release · 2015 · 198 · 8010.1016/j.jconrel.2014.12.003 ↗
25. Xiong · Biomaterials · 2012 · 33 · 718210.1016/j.biomaterials.2012.06.071 ↗
26. Nishiyama · Cancer Res. · 2003 · 63 · 8977
27. Li · ACS Appl. Mater. Interfaces · 2013 · 5 · 178110.1021/am303073u ↗
28. Manocha · J. Nanomater. · 2010 · 2010 · 78017110.1155/2010/780171 ↗
29. Viktoria · Chem. Commun. · 2011 · 47 · 1068610.1039/c1cc14230e ↗
30. Ahmed · Int. J. Pharm. · 2016 · 500 · 24510.1016/j.ijpharm.2016.01.017 ↗
31. Zhang · ACS Nano · 2015 · 9 · 865510.1021/acsnano.5b03184 ↗
32. Pierantonio · Chem. Res. Toxicol. · 2008 · 21 · 97810.1021/tx800002r ↗
33. Colbern · J. Liposome Res. · 1999 · 9 · 52310.3109/08982109909035551 ↗
34. Chen · Bioconjugate Chem. · 2012 · 23 · 175310.1021/bc200667s ↗
35. Kamendi · Toxicol. Appl. Pharmacol. · 2015 · 289 · 56010.1016/j.taap.2015.10.002 ↗
36. Ding · Journal of Cellular Immunotherapy · 2016 · 2 · 3610.1016/j.jocit.2016.02.001 ↗
37. Page · Mol. Pharmaceutics · 2014 · 11 · 171510.1021/mp500009r ↗
38. Han · Mol. Pharmaceutics · 2010 · 7 · 215610.1021/mp100185f ↗
39. Du · J. Am. Chem. Soc. · 2011 · 133 · 1756010.1021/ja207150n ↗
40. Yu · Biomacromolecules · 2015 · 16 · 264510.1021/acs.biomac.5b00460 ↗
41. Jain · Cancer Metastasis Rev. · 1990 · 9 · 25310.1007/BF00046364 ↗
42. Lin · Nanoscale · 2015 · 7 · 1483810.1039/C5NR03623B ↗
43. Kim · ACS Macro Lett. · 2016 · 5 · 29710.1021/acsmacrolett.6b00008 ↗